Comprehensive Evaluation of Anti-hyperglycemic Activity of FractionatedMomordica charantiaSeed Extract in Alloxan-Induced Diabetic Rats
Open Access
- 20 December 2012
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2012, 1-10
Abstract
The present study evaluates anti-hyperglycemic activity of fractionatedMomordica charantia(bitter gourd) seed extracts. Fasting blood glucose levels were evaluated before and after administration of different fractions of the seed extract. Among the three fractions tested, fraction Mc-3 (15 mg/kg b.wt.) showed the maximum anti-hyperglycemic activity and reduced blood glucose levels in experimental diabetic rats significantly. The activities of the key regulatory enzymes of glucose metabolism (hexokinase, pyruvate kinase, lactate dehydrogenase, and glucose-6-phosphate dehydrogenase) were determined in Mc-3-treated diabetic animals. Once-daily administration of the fraction Mc-3 for prolonged period of 18 days to the experimental diabetic animals did not result in any nephrotoxicity or hepatotoxicity as evident from insignificant changes in biochemical parameters indicative of liver and kidney functions. Further fractionation of the fraction Mc-3 by size exclusion chromatography resulted in a fraction, designated Mc-3.2, possessing anti-hyperglycemic activity. The fraction Mc-3.2 showed the presence of a predominant protein band of ~11 kDa on SDS-PAGE. Loss in anti-hyperglycemic activity of the Mc-3.2 upon protease treatment indicates the proteinaceous nature of the anti-hyperglycemic principles. Overall, the results suggest thatMomordica charantiaseeds contain an effective anti-hyperglycemic protein(s) which may find application in treatment of diabetes without evident toxic effects.Keywords
Funding Information
- Department of Biotechnology , Ministry of Science and Technology
This publication has 41 references indexed in Scilit:
- Antileukemic Potential ofMomordica charantiaSeed Extracts on Human Myeloid Leukemic HL60 CellsEvidence-Based Complementary and Alternative Medicine, 2012
- Antidiabetic Potentiality of the Aqueous‐Methanolic Extract of Seed of Swietenia mahagoni (L.) Jacq. in Streptozotocin‐Induced Diabetic Male Albino Rat: A Correlative and Evidence‐Based Approach with Antioxidative and Antihyperlipidemic ActivitiesEvidence-Based Complementary and Alternative Medicine, 2010
- Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini reviewBritish Journal of Nutrition, 2009
- Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic ratsFood and Chemical Toxicology, 2008
- An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extractBMC Complementary and Alternative Medicine, 2007
- Pathophysiology and Pharmacological Treatment of Insulin ResistanceEndocrine Reviews, 2000
- Free Radical Scavenger and Antihepatotoxic Activity ofRosmarinus tomentosusPlanta Medica, 1993
- Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceae plantsGeneral Pharmacology: The Vascular System, 1992
- Hypoglycaemic Activity of Dioscoretine from Tubers ofDioscorea dumetorumin Normal and Alloxan Diabetic RabbitsPlanta Medica, 1990
- Control of blood glucose levels in the streptozotocin diabetic rat using a long-acting heat-treated insulinDiabetologia, 1979